1991 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1991 2019

Filter
Meeting Abstract
2019

ADRIATIC: A phase III trial of durvalumab 6 tremelimumab after concurrent chemoradiation for patients with limited stage small cell lung cancer

Senan, S., Shire, N., Mak, G., Yao, W. & Jiang, H., Apr 2019, In : Annals of Oncology. 30, p. 25-25

Research output: Contribution to journalMeeting AbstractAcademic

Geometric efficacy of breath-hold gated MR-guided SABR for adrenal metastases

de Koste, J. V. S., Palacios, M., Bruynzeel, A., Spoelstra, F., Slotman, B., Lagerwaard, F. & Senan, S., Apr 2019, In : Radiotherapy and Oncology. 133, p. S212-S213

Research output: Contribution to journalMeeting AbstractAcademic

Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of SABR-Comet

Qu, M. X., Chen, Y., Zaric, G., Senan, S., Olson, R. A., Harrow, S., John-Baptiste, A., Gaede, S., Mulroy, L., Schellenberg, D., Senthi, S., Swaminath, A., Kopek, N., Liu, M., Warner, A., Rodrigues, G., Palma, D. A. & Louie, A. V., 1 Sep 2019, In : International Journal of Radiation Oncology Biology Physics. 105, 1, p. S100-S101

Research output: Contribution to journalMeeting AbstractAcademic

MR-guided adaptive radiotherapy for intra-abdominal lymphoma

Spoelstra, F., Cobussen, P., Palacios, M., Bruynzeel, A., Lagerwaard, F., Slotman, B. & Senan, S., Apr 2019, In : Radiotherapy and Oncology. 133, p. S30-S31

Research output: Contribution to journalMeeting AbstractAcademic

Patterns of Disease Progression with Durvalumab in Stage III Non-small Cell Lung Cancer (PACIFIC)

Raben, D., Rimner, A., Senan, S., Broadhurst, H., Pellas, T., Dennis, P. A. & Faivre-Finn, C., 1 Nov 2019, In : International Journal of Radiation Oncology Biology Physics. 105, 3, p. 683-683

Research output: Contribution to journalMeeting AbstractAcademic

Quality of Life Outcomes after Stereotactic Ablative Radiotherapy (SABR) vs. Standard of Care Palliative Treatments: A Secondary Analysis of the SABR-COMET Randomized Trial

Olson, R. A., Senan, S., Harrow, S., Gaede, S., Louie, A. V., Haasbeek, C., Mulroy, L., Lock, M. I., Rodrigues, G., Yaremko, B. P., Schellenberg, D., Ahmad, B., Griffioen, G., Senthi, S., Swaminath, A., Kopek, N., Liu, M., Moore, K., Currie, S., Bauman, G. S. & 2 othersWarner, A. & Palma, D. A., 1 Sep 2019, In : International Journal of Radiation Oncology Biology Physics. 105, 1, p. S72-S73

Research output: Contribution to journalMeeting AbstractAcademic

RATIONALE 001: Tislelizumab (BGB-A317) 1 concurrent chemoradiotherapy (cCRT) followed by tislelizumab monotherapy in patients (pts) with newly diagnosed locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC)

Paz-Ares, L., Senan, S., Planchard, D., Wang, L., Cheong, A., Slepetis, R., Nguyen, M. H. & Vokes, E. E., Apr 2019, In : Annals of Oncology. 30, p. 67-67

Research output: Contribution to journalMeeting AbstractAcademic

SBRT for oligometastatic NSCLC

Senan, S., Apr 2019, In : Radiotherapy and Oncology. 133, p. S356-S356

Research output: Contribution to journalMeeting AbstractAcademic

Utilization rates of stereotactic body radiation therapy for the treatment of stage I NSCLC in three European countries

Damhuis, R., Senan, S., Khakwani, A., Harden, S., Helland, A. & Strand, T-E., Apr 2019, In : Annals of Oncology. 30

Research output: Contribution to journalMeeting AbstractAcademic

2018

Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC

Faivre-Finn, C., Spigel, D. R., Senan, S., Langer, C. J., Raben, D., Perez, B., Ozguroglu, M., Daniel, D., Villegas, A., Vicente, D., Hui, R., Murakami, S., Paz-Ares, L., Poole, L., Wadsworth, C., Dennis, P. A. & Antonia, S. J., Oct 2018, In : Annals of Oncology. 29, p. 488-488

Research output: Contribution to journalMeeting AbstractAcademic

Esophagus toxicity after stereotactic radiotherapy of central lung tumor: NTCP modelling

Duijm, M., Tekatli, H., Oomen-de Hoop, E., Verbakel, W., Schillemans, W., Slotman, B. J., Senan, S. & Nuyttens, J. J., Apr 2018, In : Radiotherapy and Oncology. 127, p. S15-S15

Research output: Contribution to journalMeeting AbstractAcademic

NTCP modelling of pulmonary toxicity after stereotactic radiotherapy for central lung tumors

Tekatli, H., Duijm, M., Oomen-de Hoop, E., Verbakel, W., Schillemans, W., Slotman, B. J., Nuyttens, J. J. & Senan, S., Apr 2018, In : Radiotherapy and Oncology. 127, p. S383-S383

Research output: Contribution to journalMeeting AbstractAcademic

Patient reported outcomes after the treatment of early stage non-small cell lung cancer by stereotactic body radiotherapy compared to surgery

Alberts, L., Wolff, H. B., Kastelijn, E. A., Lagerwaard, F. J., Senan, S., El Sharouni, S. Y., Schramel, F. M. N. H. & Coupe, V. M. H., Oct 2018, In : Annals of Oncology. 29

Research output: Contribution to journalMeeting AbstractAcademic

Radiotherapy plan quality using a double focused, double stacked multi-leaf collimator

Bohoudi, O., Palacios, M. A., Slotman, B. J., Senan, S., Bruynzeel, A. M. E. & Lagerwaard, F. J., Apr 2018, In : Radiotherapy and Oncology. 127, p. S273-S273

Research output: Contribution to journalMeeting AbstractAcademic

Searching for a Definition of Synchronous Oligometastatic (sOMD)-NSCLC: A Consensus from Thoracic Oncology Experts

Dingemans, A., Hendriks, L., Berghmans, T., Levy, A., Hasan, B., Faivre-Finn, C., Levra, M. G., Giaj-Levra, N., Girard, N., Greillier, L., Lantuejoul, S., Edwards, J., O'Brien, M., Reck, M., Smit, E., Van Schil, P., Postmus, P. E., Ramella, S., Lievens, Y., Gaga, M. & 13 othersPeled, N., Scagliotti, G., Senan, S., Paz-Ares, L., Guckenberger, M., Mcdonald, F., Ekman, S., Cufer, T., Gietema, H., Infante, M., Dziadziuszko, R., Besse, B. & Novello, S., Oct 2018, In : Journal of Thoracic Oncology. 13, 10, p. S446-S446

Research output: Contribution to journalMeeting AbstractAcademic

Stereotactic Ablative Radiation Therapy for the Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): Results of a Randomized Trial

Palma, D. A., Olson, R. A., Harrow, S., Gaede, S., Louie, A. V., Haasbeek, C., Mulroy, L. A., Lock, M. I., Rodrigues, G., Yaremko, B. P., Schellenberg, D., Ahmad, B., Griffioen, G., Senthi, S., Liu, M. C., Moore, K., Currie, S., Bauman, G. S., Warner, A. & Senan, S., 1 Nov 2018, In : International Journal of Radiation Oncology Biology Physics. 102, 3, p. S3-S4

Research output: Contribution to journalMeeting AbstractAcademic

Stereotactic ablative radiotherapy for oligometastatic cancers: Efficacy and toxicity results from the randomized SABR-COMET Trial

Senan, S., Olson, R., Harrow, S., Gaede, S., Louie, A., Haasbeek, C., Mulroy, L., Lock, M., Rodrigues, G., Yaremko, B., Schellenberg, D., Ahmad, B., Griffioen, G., Senthi, S., Liu, M., Moore, K., Currie, S., Bauman, G., Warner, A. & Palma, D., Nov 2018, In : Annals of Oncology. 29

Research output: Contribution to journalMeeting AbstractAcademic

2017

Complete endosonographic nodal staging of lung cancer in patients eligible for stereotactic ablative radiotherapy (STAGE study NCT02997449)

Crombag, L. M. M. J., Annema, J., Dieleman, E., Bonta, P., Hashemi, S., Buikhuisen, W., Chuurbiers, O. S., Szlubowski, A., Senan, S. & van der Wekken, A., 1 Sep 2017, In : European Respiratory Journal. 50

Research output: Contribution to journalMeeting AbstractAcademic

Estimated Benefit of Dose Reduction to Highly Ventilated Lung Regions for Stage III Non-small Cell Lung Cancer Patients Using Normal Tissue Complication Probability Models

Zhang, H. H., Mohindra, P., Simone, C. B. . II., Bentzen, S. M., Senan, S., de Koste, J. R. V. S., Jeudy, J. & D'Souza, W. D., 1 Oct 2017, In : International Journal of Radiation Oncology Biology Physics. 99, 2, p. S109-S109

Research output: Contribution to journalMeeting AbstractAcademic

Identifying Barriers to Accrual in Radiation Oncology Randomized Trials: Insights From a Trial of Stereotactic Radiation for Oligometastatic Disease

Laba, J. M., Senan, S., Schellenberg, D., Harrow, S., Mulroy, L., Senthi, S., Swaminath, A., Kopek, N., Pantarotto, J. R., Pan, L. M., Pearce, A. G. . J., Warner, A., Louie, A. V. & Palma, D. A., 1 Oct 2017, In : International Journal of Radiation Oncology Biology Physics. 99, 2, p. E403-E403

Research output: Contribution to journalMeeting AbstractAcademic

Increased Treatment-Related Toxicity in Patients with Early-Stage Non-Small Cell Lung Cancer and Co-Existing Interstitial Lung Disease

Chen, H., Louie, A., Nossent, E., Boldt, G., Palma, D. & Senan, S., Jan 2017, In : Journal of Thoracic Oncology. 12, 1, p. S652-S653

Research output: Contribution to journalMeeting AbstractAcademic

Optimal Imaging Follow-up Schedules after Stereotactic Ablative Radiotherapy for Early Non-Small-Cell Lung Cancer: Findings of an International Delphi Consensus Study

Nguyen, T., Senan, S., Bradley, J. D., Franks, K. N., Giuliani, M. E., Guckenberger, M., Landis, M., Loo, B. W. . J., Louie, A. V., Onishi, H., Schmidt, H., Timmerman, R. D., Videtic, G. M. & Palma, D. A., 1 Oct 2017, In : International Journal of Radiation Oncology Biology Physics. 99, 2, p. S241-S242

Research output: Contribution to journalMeeting AbstractAcademic

Radiation Therapy for Superior Sulcus Tumor

Senan, S., Nov 2017, In : Journal of Thoracic Oncology. 12, 11, p. S1696-S1697

Research output: Contribution to journalMeeting AbstractAcademic

Radiotherapy Quality Assurance of Concurrent Chemoradiotherapy in PROCLAIM Phase III Trial

Brade, A., Wenz, F., Koppe, F., Lievens, Y., San Antonio, B., Iscoe, N., Hossain, A., Chouaki, N. & Senan, S., Jan 2017, In : Journal of Thoracic Oncology. 12, 1, p. S338-S338

Research output: Contribution to journalMeeting AbstractAcademic

Stereotactic Ablative Radiotherapy Versus Surgery in Early Lung Cancer: A Meta-Analysis of Propensity Score-Adjusted Comparative Effectiveness Studies

Chen, H., Laba, J. M., Boldt, G., Goodman, C. D., Palma, D. A., Senan, S. & Louie, A. V., 1 Oct 2017, In : International Journal of Radiation Oncology Biology Physics. 99, 2, p. E445-E445

Research output: Contribution to journalMeeting AbstractAcademic

Stereotactic Ablative Radiotherapy Versus Surgery in Early Lung Cancer: A Meta-analysis of Propensity Score-Adjusted Studies

Chen, H., Laba, J., Boldt, R. G., Goodman, C., Palma, D., Senan, S. & Louie, A., Nov 2017, In : Journal of Thoracic Oncology. 12, 11, p. S1787-S1788

Research output: Contribution to journalMeeting AbstractAcademic

The Role of Radiotherapy in Early-Stage NSCLC

Senan, S., Jan 2017, In : Journal of Thoracic Oncology. 12, 1, p. S42-S43

Research output: Contribution to journalMeeting AbstractAcademic

Treatment-Related Toxicity in Patients with Early Stage Non-Small Cell Lung Cancer and Co-Existing Interstitial Lung Disease: A Systematic Review

Chen, H., Senan, S., Nossent, E. J., Boldt, G., Warner, A., Palma, D. A. & Louie, A. V., 1 May 2017, In : International Journal of Radiation Oncology Biology Physics. 98, 1, p. 245-246

Research output: Contribution to journalMeeting AbstractAcademic

2016

Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy (SABR) for Lung Cancer: Physician Performance Versus Radiomic Assessment

Mattonen, S. A., Palma, D. A., Johnson, C., Louie, A. V., Landis, M., Rodrigues, G., Chan, I., Etemad-Rezai, R., Yeung, T. P. C., Senan, S. & Ward, A. D., 1 Oct 2016, In : International Journal of Radiation Oncology Biology Physics. 96, 2, p. S48-S48

Research output: Contribution to journalMeeting AbstractAcademic

Identifying Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Most Likely to Benefit From Intensive Radiation Therapy

Slotman, B. J., Faivre-Finn, C., van Tinteren, H., Keijser, A., Praag, J. O., Knegjens, J., Hatton, M., van Dam, I., van der Leest, A., Reymen, B., Stigt, J., Haslett, K., Tripathi, D., Smit, E. & Senan, S., 1 Oct 2016, In : International Journal of Radiation Oncology Biology Physics. 96, 2, p. S153-S154

Research output: Contribution to journalMeeting AbstractAcademic

Quality of Life Following Stereotactic Ablative Radiation Therapy Versus Surgery for Early-Stage Lung Cancer: Results From the ROSEL Randomized Controlled Trial and a Systematic Review

Louie, A. V., Chen, H., Van Werkhoven, E., Smit, E., Palma, D. A., Paul, M. A., Warner, A., Widder, J., Groen, H. J. M., van Den Borne, B., De Jaeger, K., Rodrigues, G., Slotman, B. J. & Senan, S., 1 Oct 2016, In : International Journal of Radiation Oncology Biology Physics. 96, 2, p. S10-S11

Research output: Contribution to journalMeeting AbstractAcademic

The impact of staging by positron emission tomography (PET) on overall survival (OS) and progression-free survival (PFS) in the phase III PROCLAIM study

Iscoe, N., Govindan, R., Hossain, A. M., San Antonio, B., Chouaki, N., Koczywas, M., Vokes, E. & Senan, S., 1 Oct 2016, In : Annals of Oncology. 27

Research output: Contribution to journalMeeting AbstractAcademic

Defining Target Volumes for Radiotherapy of Peripheral Lung Tumors: A Comparison of F-18-FDG-positron Emission Tomography and 4-dimensional CT Scans

Hanna, G. G., van Sornsen de Koste, J. R., Dahele, M. R., Carson, K. J., Haasbeek, C. J. A., Migchielsen, R., Hounsell, A. R. & Senan, S., 2010, In : International journal of radiation oncology, biology, physics. 78, 3, p. S528-S528

Research output: Contribution to journalMeeting AbstractOther research output

Defining target volumes for treatment of peripheral lung tumours with radiotherapy: A comparison of 18F-FDG-positron emission tomography and 4-dimensional CT scanning

Hanna, G. G., van Sornsen de Koste, J. R., Dahele, M. R., Carson, K., Haasbeek, C. J. A., Migchielsen, R., Hounsell, A. & Senan, S., 2010, In : Lung Cancer. 67, p. 98

Research output: Contribution to journalMeeting AbstractOther research output